Therapeutic effectiveness and tolerance to the treatment did not differ between olsalazine sodium , 3 g/day , and mesalazine , 3 g/day , in inducing endoscopic remission in patients with mild to moderate active ulcerative colitis within 12 weeks of treatment .
